The U.S. Food and Drug Administration amended its emergency use authorization for the Pfizer-BioNTech COVID-19 vaccine to allow for booster shots for certain populations.
The U.S. Food and Drug Administration amended its emergency use authorization for the Pfizer-BioNTech COVID-19 vaccine to allow for booster shots for certain populations.